Replies to post #136312 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

From the 10K

Our directors and executive officers, their age, positions held, and duration of such, are as follows:



Name Position Age Date first appointed
Christopher Missling, PhD Director, President, Chief Executive Officer, Secretary 52 July 5, 2013
Athanasios Skarpelos Director 51 January 9, 2013
Bernd Metzner, PhD Director 47 May 7, 2014
Elliot Favus, MD Director 43 May 7, 2014
Steffen Thomas, PhD Director 51 June 15, 2015
Peter Donhauser, D.O. Director 52 February 8, 2017
Sandra Boenisch Principal Financial Officer, Treasurer 36 October 1, 2015

From SEC

Corporate insiders – meaning a company's officers and directors, and any beneficial owners of more than ten percent of a class of the company's equity securities registered under Section 12 of the Securities Exchange Act of 1934 – must file with the SEC a statement of ownership regarding those securities. On August 27, 2002, the SEC adopted rules and amendments to Section 16 of the Exchange Act, implementing the provisions of the Sarbanes-Oxley Act of 2002 that accelerated the deadline for filing most insider ownership reports.

So I would say that until and if we see a From-4 confirming that Sandra Boenisch Principal Financial Officer, Treasurer has sold shares, it ain't so.